-
Signature
-
/s/ Sriram Ryali, as Attorney-in-Fact for John J. Nicols
-
Issuer symbol
-
CDXS
-
Transactions as of
-
17 Apr 2023
-
Net transactions value
-
-$158,538
-
Form type
-
4
-
Filing time
-
19 Apr 2023, 16:18:46 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CDXS |
Common Stock |
Options Exercise |
$70,357 |
+35,714 |
+4.6% |
$1.97 |
819,679 |
17 Apr 2023 |
Direct |
F1 |
| transaction |
CDXS |
Common Stock |
Sale |
$151,377 |
-35,714 |
-4.4% |
$4.24 |
783,965 |
17 Apr 2023 |
Direct |
F1, F2 |
| transaction |
CDXS |
Common Stock |
Options Exercise |
$70,357 |
+35,714 |
+4.6% |
$1.97 |
819,679 |
18 Apr 2023 |
Direct |
F1 |
| transaction |
CDXS |
Common Stock |
Sale |
$147,874 |
-35,714 |
-4.4% |
$4.14 |
783,965 |
18 Apr 2023 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CDXS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-35,714 |
-17% |
$0.000000 |
178,570 |
17 Apr 2023 |
Common Stock |
35,714 |
$1.97 |
Direct |
F1 |
| transaction |
CDXS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-35,714 |
-20% |
$0.000000 |
142,856 |
18 Apr 2023 |
Common Stock |
35,714 |
$1.97 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: